WAM
INFI

Wealthspire Advisors (Maryland)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,200
Closed -$2K – 2221
2019
Q1 		$2K Buy
+1,200
New +$1.76K ﹤0.01% 2238

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s INFI Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2019, closing a stake of 1,200 shares — an estimated $2K sold.

Wealthspire Advisors (Maryland) first reported a position in INFI in Q1 2019 and held it in 1 quarter. The position peaked at $2K in Q1 2019. 55 funds tracked by Wall St. Rank hold INFI as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 1,200 Infinity Pharmaceuticals, Inc. shares in Q2 2019, an estimated $2K.
  • Wealthspire Advisors (Maryland) first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2019 and held it in 1 quarter.
  • Wealthspire Advisors (Maryland)'s Infinity Pharmaceuticals, Inc. position peaked at $2K in Q1 2019.
  • 55 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.